Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis.
D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects*; D007136:Immunoglobulins / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D012189:Retrospective Studies; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D018029:Rho(D) Immune Globulin; D012306:Risk; D013997:Time Factors
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin